Trial intelligence / Profile preview

Perioperative 5-FU in Colon Cancer

NCT00002525Phase 3Terminated

Sponsor
ECOG-ACRIN Cancer Research Group
Start
Oct 1993
Primary completion
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fluorouracil in colon adenocarcinoma, sponsored by ECOG-ACRIN Cancer Research Group. Started Oct 1993; status: terminated.

02

Drugs

fluorouracil
03

Conditions

colon adenocarcinoma

Beyond the preview

Go deeper on NCT00002525.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002525.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call